Newborn Screening for Sickle Cell Disease: Technical and Legal Aspects of a German Pilot Study with 38,220 Participants

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Frömmel, Claudia ^a,b   Brose, Annemarie ^a   Klein, Jeannette ^a   Blankenstein, Oliver ^a   Lobitz, Stephan ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Instand eV   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GERMANIC PEOPLE; GERMANY; HEALTH CARE COST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LEGAL ASPECT; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; NEWBORN; NEWBORN SCREENING; PILOT STUDY; SICKLE CELL ANEMIA; ANEMIA, SICKLE CELL; CROSS-SECTIONAL STUDY; ETHNIC GROUP; HEMOGLOBINOPATHIES; PROCEDURES; RETROSPECTIVE STUDY;

ANEMIA, SICKLE CELL; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; GERMANY; HEMOGLOBINOPATHIES; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; PILOT PROJECTS; RETROSPECTIVE STUDIES;

EID: 84908120893     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/695828     Document Type: Article

References (51)

1. D. C. Rees, T. N. Williams, and M. T. Gladwin, "Sickle-cell disease, " The Lancet, vol. 376, no. 9757, pp. 2018-2031, 2010.
2. D. Powars, G. Overturf, J. Weiss, S. Lee, and L. Chan, "Pneumococcal septicemia in children with sickle cell anemia. Changing trend of survival, " Journal of the AmericanMedical Association, vol. 245, no. 18, pp. 1839-1842, 1981.
3. A. M. Emond, R. Collis, D. Darvill, D. R. Higgs, G. H. Maude, and G. R. Serjeant, "Acute splenic sequestration in homozygous sickle cell disease: natural history and management, " The Journal of Pediatrics, vol. 107, no. 2, pp. 201-206, 1985.
4. M. H. Gaston, J. I. Verter, G. Woods, et al., "Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial, "The New England Journal of Medicine, vol. 314, no. 25, pp. 1593-1599, 1986.
5. G. R. Serjeant and B. E. Serjeant, "Management of sickle cell disease; lessons fromthe Jamaican cohort study, " Blood Reviews, vol. 7, no. 3, pp. 137-145, 1993.
6. A. Lee, P. Thomas, L. Cupidore, B. Serjeant, and G. Serjeant, "Improved survival in homozygous sickle cell disease: lessons from a cohort study, " British Medical Journal, vol. 311, no. 7020, pp. 1600-1602, 1995.
7. T. V. Adamkiewicz, S. Sarnaik, G. R. Buchanan, et al., "Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination, " Journal of Pediatrics, vol. 143, no. 4, pp. 438-444, 2003.
8. N. B. Halasa, S. M. Shankar, T. R. Talbot, et al., "Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine, " Clinical Infectious Diseases, vol. 44, no. 11, pp. 1428-1433, 2007.
9. T. V. Adamkiewicz, B. J. Silk, J. Howgate, et al., "Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life, " Pediatrics, vol. 121, no. 3, pp. 562-569, 2008.
10. S. D. Grosse, H. K. Atrash, I. Odame, D. Amendah, F. B. Piel, and T. N. Williams, "The Jamaican historical experience of the impact of educational interventions on sickle cell disease child mortality, " The American Journal of PreventiveMedicine, vol. 42, no. 6, pp. e101-e103, 2012.
11. H. Heijboer, X. W. van den Tweel, M. Peters, M. Knuist, J. Prins, and H. S. Heymans, "One year of neonatal screening for sickle cell disease in the emma kinderziekenhuis/academisch medisch centrum, Amsterdam, " Nederland s Tijdschrift voor Geneeskunde, vol. 145, no. 37, pp. 1795-1799, 2001.
12. B. Gulbis, F. Cotton, A. Ferster, et al., "Neonatal haemoglobinopathy screening in Belgium, " Journal of Clinical Pathology, vol. 62, no. 1, pp. 49-52, 2009.
13. A. Streetly, R. Latinovic, and J. Henthorn, "Positive screening and carrier results for the England-wide universal newborn sickle cell screening programme by ethnicity and area for 2005-07, " Journal of Clinical Pathology, vol. 63, no. 7, pp. 626-629, 2010.
14. E. Ballardini, A. Tarocco, M. Marsella, et al., "Universal neonatal screening for sickle cell disease and other haemoglobinopathies in Ferrara, Italy, " Blood Transfusion, vol. 11, no. 2, pp. 245-249, 2013.
15. J. Bardakdjian-Michau, M. Bahuau, D. Hurtrel, et al., "Neonatal screening for sickle cell disease in France, " Journal of Clinical Pathology, vol. 62, no. 1, pp. 31-33, 2009.
16. E. Cela De Julian, E. Dulin I niguez, M. Guerrero Soler, et al., "Evaluation of systematic neonatal screening for sickle cell diseases in Madrid three years after its introduction, " Anales de Pediatria, vol. 66, no. 4, pp. 382-386, 2007.
17. M. J. Bouva, K. Mohrmann, H. B. J. M. Brinkman, et al., "Implementing neonatal screening for haemoglobinopathies in the Netherlands, " Journal of Medical Screening, vol. 17, no. 2, pp. 58-65, 2010.
18. P. C. Giordano, M. J. Bouva, and C. L. Harteveld, "A confidential inquiry estimating the number of patients affected with sickle cell disease and thalassemia major confirms the need for a prevention strategy in theNetherlands, " Hemoglobin, vol. 28, no. 4, pp. 287-296, 2004.
19. S. Berthet, F. Monpoux, A.-M. Soummer, E. Berard, J. Sarles, and C. Badens, "Neonatal screening for sickle cell disease in Nice University Hospital: review of 8 last years, " Archives de Pediatrie, vol. 17, no. 12, pp. 1652-1656, 2010.
20. R. Ducrocq, M. Benkerrou, L. Brahimi, et al., "Neonatal screening for sickle cell anemia: evaluation of a five-year experience in an area of northern Paris, " Archives de Pediatrie, vol. 8, no. 5, pp. 474-480, 2001.
21. M. Manu Pereira and J. Vives Corrons, "Neonatal haemoglobinopathy screening in Spain, " Journal of Clinical Pathology, vol. 62, no. 1, pp. 22-25, 2009.
22. C. Saint-Martin, M. Romana, A. Bibrac, et al., "Universal newborn screening for haemoglobinopathies in Guadeloupe (French West Indies): a 27-year experience, " Journal of Medical Screening, vol. 20, no. 4, pp. 177-182, 2013.
23. C. L. Lobo, S. K. Ballas, A. C. Domingos, P. G. Moura, E. M. do Nascimento, and G. P. Cardoso, "Newborn screening program for hemoglobinopathies in Rio de Janeiro, Brazil, " Pediatric Blood and Cancer, vol. 61, no. 1, pp. 34-39, 2014.
24. P. T. McGann, M. G. Ferris, U. Ramamurthy, et al., "A prospective newborn screening and treatment program for sickle cell anemia in Luand a, Angola, "The American Journal of Hematology, vol. 88, no. 12, pp. 984-989, 2013.
25. J. Patel and G. R. Serjeant, "Newborn screening for sickle cell disease in India: the need for defining optimal clinical care, " Indian Journal of Pediatrics, vol. 81, no. 3, pp. 229-230, 2014.
26. S. Hajer, T. Neila, H. F. Sondess, et al., "A lower-cost protocol for sickle cell disease neonatal screening in Tunisia, " Annals of Saudi Medicine, vol. 32, no. 1, pp. 49-52, 2012.
27. V. S. Hertzberg, C. F. Hinton, B. L. Therrell, and S. K. Shapira, "Birth prevalence rates of newborn screening disorders in relation to screening practices in the United States, " Journal of Pediatrics, vol. 159, no. 4, pp. 555-560, 2011.
28. M. C. Rahimy, A. Gangbo, G. Ahouignan, and E. Alihonou, "Newborn screening for sickle cell disease in the Republic of Benin, " Journal of Clinical Pathology, vol. 62, no. 1, pp. 46-48, 2009.
29. E. Kafando, E. Nacoulma, Y. Ouattara, et al., "Neonatal haemoglobinopathy screening in Burkina Faso, " Journal of Clinical Pathology, vol. 62, no. 1, pp. 39-41, 2009.
30. L. Tshilolo, L. M. Aissi, D. Lukusa, et al., "Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience froma pioneer project on 31 204 newborns, " Journal of Clinical Pathology, vol. 62, no. 1, pp. 35-38, 2009.
31. B. J. Bain, "Haemoglobinopathy diagnosis: algorithms, lessons and pitfalls, " Blood Reviews, vol. 25, no. 5, pp. 205-213, 2011.
32. K. Ryan, B. J. Bain, D. Worthington, et al., "Significant haemoglobinopathies: guidelines for screening and diagnosis, " British Journal of Haematology, vol. 149, no. 1, pp. 35-49, 2010.
33. J. Riou, C. Godart, D. Hurtrel, et al., "Cation-exchange HPLC evaluated for presumptive identification of hemoglobin variants, " Clinical Chemistry, vol. 43, no. 1, pp. 34-39, 1997.
34. G. Renom, C. Mereau, P. Maboudou, and J.-M. Perini, "Potential of the Sebia Capillarys neonat fast automated system for neonatal screening of sickle cell disease, " Clinical Chemistry and Laboratory Medicine, vol. 47, no. 11, pp. 1423-1432, 2009.
35. M. Campbell, J. S. Henthorn, and S. C. Davies, "Evaluation of cation-exchange HPLC compared with isoelectric focusing for neonatal hemoglobinopathy screening, " Clinical Chemistry, vol. 45, no. 7, pp. 969-975, 1999.
36. E. Mantikou, C. L. Harteveld, and P. C. Giordano, "Newborn screening for hemoglobinopathies using capillary electrophoresis technology: testing the Capillarys Neonat Fast Hb device, " Clinical Biochemistry, vol. 43, no. 16-17, pp. 1345-1350, 2010.
37. F. Kutlar, "Diagnostic approach to hemoglobinopathies, " Hemoglobin, vol. 31, no. 2, pp. 243-250, 2007.
38. G. Bundesausschuss, Anlage 2: Erweitertes Neugeborenenscreening, 2010, http://www.g-ba.de/downloads/83-691-233/RL Kinder Anlage-2-2010-12-16.pdf.
39. A. Andermann, I. Blancquaert, S. Beauchamp, and I. Costea, "Guiding policy decisions for genetic screening: developing a systematic and transparent approach, " Public Health Genomics, vol. 14, no. 1, pp. 9-16, 2010.
40. A. Andermann, I. Blancquaert, S. Beauchamp, and V. Dery, "RevisitingWilson and Jungner in the genomic age: a review of screening criteria over the past 40 years, " Bulletin of the World Health Organization, vol. 86, no. 4, pp. 317-319, 2008.
41. S. Lobitz, C. Frommel, A. Brose, J. Klein, and O. Blankenstein, "Incidence of sickle cell disease in an unselected cohort of neonates born in Berlin, Germany, " European Journal of Human Genetics, 2014.
42. P. D. Roa, E. A. Turner, and M. D. P. Aguinaga, "Hemoglobin variant detection from dried blood specimens by high performance liquid chromatography, " Annals of Clinical and Laboratory Science, vol. 23, no. 6, pp. 433-438, 1993.
43. C. Murray, S. K. Hall, and P. Griffiths, "Anevaluationof the Sebia capillarys Neonat Haemoglobin FAST? system for routine newborn screening for sickle cell disease, " International Journal of Laboratory Hematology, vol. 33, no. 5, pp. 533-539, 2011.
44. A. F. S. B. Brand enburg, "Statistisches Jahrbuch 2011, " 2011, https://www.statistik-berlin-brand enburg.de/produkte/Jahrbuch/jb2011/JB-2011-BE.pdf.
45. E. Harms and B. Olgemoller, "Neonatal screening for metabolic and endocrine disorders, " Deutsches Arzteblatt International, vol. 108, no. 1-2, pp. 11-22, 2011.
46. A. Joutovsky, J. Hadzi-Nesic, and M. A. Nardi, "HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60 000 samples in a clinical diagnostic laboratory, " Clinical Chemistry, vol. 50, no. 10, pp. 1736-1747, 2004.
47. E. Kohne and E. Kleihauer, "Hemoglobinopathies in Germany-a longitudinal study over four decades, " Deutsches Arzteblatt, vol. 107, no. 5, pp. 65-71, 2010.
48. R. Dickerhof f, O. Genzel-Boroviczeny, and E. Kohne, "Haemoglobinopathies and newborn haemoglobinopathy screening in Germany, " Journal of Clinical Pathology, vol. 62, no. 1, article 34, 2009.
49. Enactment of the German Federal Parliament (Bundestag), "Human Genetic Examination Act (Genetic Diagnosis Act-GenDG), " 2009, https://www.eshg.org/fileadmin/www.eshg.org/documents/Europe/LegalWS/Germany-GenDG-Law-German-English.pdf.
50. J. M. Wilson and Y. G. Jungner, Principles and Practice of Mass Screening for Disease, WHOPublicHealth Papers, 1968.
51. Gendiagnostik-Kommission, "Richtlinien der Gendiagnostik- Komission (GEKO) fur die Anforderung an die Durchfuhrung genetischer Reihenuntersuchungen gema 23 Abs. 2 Nr. 6 GenDG, " Bundesgesundheitsblatt, vol. 56, pp. 321324, 2012.